.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Accenture
Harvard Business School
Novartis
Express Scripts
Baxter
Boehringer Ingelheim
Healthtrust
Argus Health
Moodys

Generated: January 19, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to United Kingdom Patent: 9921933

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Valeant IntlCARDIZEM LAdiltiazem hydrochlorideTABLET, EXTENDED RELEASE;ORAL021392-001Feb 6, 2003ABRXYesNo➤ Subscribe➤ SubscribeY
Valeant IntlCARDIZEM LAdiltiazem hydrochlorideTABLET, EXTENDED RELEASE;ORAL021392-002Feb 6, 2003ABRXYesNo➤ Subscribe➤ SubscribeY
Valeant IntlCARDIZEM LAdiltiazem hydrochlorideTABLET, EXTENDED RELEASE;ORAL021392-003Feb 6, 2003ABRXYesNo➤ Subscribe➤ SubscribeY
Valeant IntlCARDIZEM LAdiltiazem hydrochlorideTABLET, EXTENDED RELEASE;ORAL021392-004Feb 6, 2003ABRXYesNo➤ Subscribe➤ SubscribeY
Valeant IntlCARDIZEM LAdiltiazem hydrochlorideTABLET, EXTENDED RELEASE;ORAL021392-005Feb 6, 2003ABRXYesNo➤ Subscribe➤ SubscribeY
Valeant IntlCARDIZEM LAdiltiazem hydrochlorideTABLET, EXTENDED RELEASE;ORAL021392-006Feb 6, 2003ABRXYesYes➤ Subscribe➤ SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist